Breast Cancer Stocks List

Recent Signals

Date Stock Signal Type
2019-10-18 ATOS Calm After Storm Range Contraction
2019-10-18 ATOS NR7 Range Contraction
2019-10-18 ATOS Narrow Range Bar Range Contraction
2019-10-18 AZN Fell Below 20 DMA Bearish
2019-10-18 BPMX Volume Surge Other
2019-10-18 BPMX Crossed Above 20 DMA Bullish
2019-10-18 BPMX 50 DMA Resistance Bearish
2019-10-18 BPMX Pocket Pivot Bullish Swing Setup
2019-10-18 BPMX Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-10-18 BPMX Bollinger Band Squeeze Range Contraction
2019-10-18 BPMX Lizard Bearish Bearish Day Trade Setup
2019-10-18 BPMX Shooting Star Candlestick Bearish
2019-10-18 BPMX Wide Range Bar Range Expansion
2019-10-18 BPTH Calm After Storm Range Contraction
2019-10-18 BPTH 50 DMA Resistance Bearish
2019-10-18 CLVS Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-10-18 CLVS 1,2,3 Retracement Bearish Bearish Swing Setup
2019-10-18 CLVS 20 DMA Resistance Bearish
2019-10-18 CRIS NR7-2 Range Contraction
2019-10-18 CRIS NR7 Range Contraction
2019-10-18 CRIS Narrow Range Bar Range Contraction
2019-10-18 GENE 50 DMA Support Bullish
2019-10-18 GENE Pocket Pivot Bullish Swing Setup
2019-10-18 GENE 20 DMA Support Bullish
2019-10-18 GHDX Stochastic Sell Signal Bearish
2019-10-18 HOLX Pocket Pivot Bullish Swing Setup
2019-10-18 HOLX Cup with Handle Other
2019-10-18 HOLX Crossed Above 50 DMA Bullish
2019-10-18 HOLX 20 DMA Support Bullish
2019-10-18 ICAD Wide Range Bar Range Expansion
2019-10-18 ICAD Volume Surge Other
2019-10-18 ICAD Calm After Storm Range Contraction
2019-10-18 ISR Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-10-18 OCX NR7-2 Range Contraction
2019-10-18 OCX NR7 Range Contraction
2019-10-18 OCX Narrow Range Bar Range Contraction
2019-10-18 PDSB New 52 Week Low Weakness
2019-10-18 PDSB MACD Bearish Signal Line Cross Bearish
2019-10-18 PDSB New 52 Week Closing Low Bearish
2019-10-18 RDUS MACD Bullish Centerline Cross Bullish
2019-10-18 SLRX Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-10-18 SLRX Bollinger Band Squeeze Range Contraction
2019-10-18 SLRX Narrow Range Bar Range Contraction
2019-10-18 SNDX 20 DMA Resistance Bearish
2019-10-18 SNDX Bearish Engulfing Bearish
2019-10-18 SNDX 1,2,3 Retracement Bearish Bearish Swing Setup
2019-10-18 SNDX Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-10-18 TCON Volume Surge Other
2019-10-18 TCON Pocket Pivot Bullish Swing Setup

Breast cancer is cancer that develops from breast tissue. Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, fluid coming from the nipple, a newly inverted nipple, or a red or scaly patch of skin. In those with distant spread of the disease, there may be bone pain, swollen lymph nodes, shortness of breath, or yellow skin.Risk factors for developing breast cancer include being female, obesity, lack of physical exercise, drinking alcohol, hormone replacement therapy during menopause, ionizing radiation, early age at first menstruation, having children late or not at all, older age, prior history of breast cancer, and family history. About 5–10% of cases are due to genes inherited from a person's parents, including BRCA1 and BRCA2 among others. Breast cancer most commonly develops in cells from the lining of milk ducts and the lobules that supply the ducts with milk. Cancers developing from the ducts are known as ductal carcinomas, while those developing from lobules are known as lobular carcinomas. In addition, there are more than 18 other sub-types of breast cancer. Some cancers, such as ductal carcinoma in situ, develop from pre-invasive lesions. The diagnosis of breast cancer is confirmed by taking a biopsy of the concerning lump. Once the diagnosis is made, further tests are done to determine if the cancer has spread beyond the breast and which treatments are most likely to be effective.The balance of benefits versus harms of breast cancer screening is controversial. A 2013 Cochrane review stated that it is unclear if mammographic screening does more good or harm. A 2009 review for the US Preventive Services Task Force found evidence of benefit in those 40 to 70 years of age, and the organization recommends screening every two years in women 50 to 74 years old. The medications tamoxifen or raloxifene may be used in an effort to prevent breast cancer in those who are at high risk of developing it. Surgical removal of both breasts is another preventative measure in some high risk women. In those who have been diagnosed with cancer, a number of treatments may be used, including surgery, radiation therapy, chemotherapy, hormonal therapy and targeted therapy. Types of surgery vary from breast-conserving surgery to mastectomy. Breast reconstruction may take place at the time of surgery or at a later date. In those in whom the cancer has spread to other parts of the body, treatments are mostly aimed at improving quality of life and comfort.Outcomes for breast cancer vary depending on the cancer type, extent of disease, and person's age. Survival rates in the developed world are high, with between 80% and 90% of those in England and the United States alive for at least 5 years. In developing countries survival rates are poorer. Worldwide, breast cancer is the leading type of cancer in women, accounting for 25% of all cases. In 2012 it resulted in 1.68 million new cases and 522,000 deaths. It is more common in developed countries and is more than 100 times more common in women than in men.

More about Breast Cancer